DYOR. Analysis is highly-speculative. The analysis assumes RACE are successful in their strategy to prove up value of Zantrene in terms of clinical safety and efficacy for a range of cancer, camcer/cardio-protection and cardio-renal targets and then successfully achieve a commercial transaction. Potential outcomes include buyout, partnership or independent commercialisation.
Further to this, US-listed early-stage precision oncology companies are trading an a median market cap of USD $1.03B ( AUD $1.44B ) or around $8 per share fully-diluted.
RAC is significantly undervalued.
Here's a summary of my analysis with value indicators plotted on a chart - buyouts, partnerships, early-stage peers.
RAC is in a long-term uptrend. At the moment we have consolidation underway. I think this will eventually breakout (could take 4-5 months) for significant upside once the big seller runs out of stock.
- Forums
- ASX - By Stock
- RAC
- Ann: Expanded Heart Protection Discovery for Zantrene
Ann: Expanded Heart Protection Discovery for Zantrene, page-62
- There are more pages in this discussion • 325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
-0.060(3.64%) |
Mkt cap ! $274.7M |
Open | High | Low | Value | Volume |
$1.65 | $1.67 | $1.51 | $190.6K | 118.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1277 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 504 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6588 | 1.530 |
2 | 1005 | 1.525 |
4 | 8744 | 1.520 |
1 | 3000 | 1.500 |
1 | 10000 | 1.490 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 3152 | 1 |
1.595 | 3429 | 1 |
1.600 | 1600 | 1 |
1.610 | 392 | 1 |
1.620 | 1936 | 1 |
Last trade - 13.41pm 04/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.62 |
  |
Change
-0.060 ( 1.22 %) |
|||
Open | High | Low | Volume | ||
$1.66 | $1.68 | $1.52 | 17693 | ||
Last updated 13.58pm 04/06/2024 ? |
Featured News
RAC (ASX) Chart |